Owens & Minor Stock Price, News & Analysis (NYSE:OMI)

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Owens & Minor announced a quarterly dividend on Wednesday, August 7th. Investors of record on Monday, September 16th will be given a dividend of $0.002 per share on Monday, September 30th. This represents a $0.01 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Friday, September 13th. View Owens & Minor's Dividend History.

Owens & Minor, Inc. (NYSE:OMI) released its quarterly earnings results on Wednesday, August, 7th. The company reported $0.10 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.07 by $0.03. The company earned $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Owens & Minor had a negative net margin of 2.88% and a positive return on equity of 5.53%. The business's revenue was up 1.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.32 EPS. View Owens & Minor's Earnings History.

Owens & Minor is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for Owens & Minor.

Owens & Minor issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $0.60-0.70 for the period, compared to the Thomson Reuters consensus estimate of $0.61.

5 Wall Street analysts have issued 12-month target prices for Owens & Minor's shares. Their predictions range from $5.00 to $9.00. On average, they anticipate Owens & Minor's share price to reach $7.30 in the next year. This suggests a possible upside of 30.1% from the stock's current price. View Analyst Price Targets for Owens & Minor.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Owens & Minor.

News articles about OMI stock have been trending somewhat negative recently, InfoTrie reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Owens & Minor earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Owens & Minor.

Some companies that are related to Owens & Minor include Enanta Pharmaceuticals (ENTA), Orchard Therapeutics (ORTX), Gossamer Bio (GOSS), G1 Therapeutics (GTHX), Radius Health (RDUS), Health Catalyst (HCAT), STAAR Surgical (STAA), Momenta Pharmaceuticals (MNTA), Sienna Senior Living (SIA), National HealthCare (NHC), Alector (ALEC), Theravance Biopharma (TBPH), Veracyte (VCYT), Opko Health (OPK) and Clinigen Group (CLIN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include AT&T (T), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA), Omega Healthcare Investors (OHI), Applied Materials (AMAT), Cisco Systems (CSCO), Tanger Factory Outlet Centers (SKT), 3M (MMM) and Simon Property Group (SPG).

Owens & Minor's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.86%), Vanguard Group Inc. (7.55%), JPMorgan Chase & Co. (4.55%), Blackstone Group Inc (4.11%), Invesco Ltd. (3.82%) and Morgan Stanley (2.86%). Company insiders that own Owens & Minor stock include Charles C Colpo and Geoff Taylor Marlatt. View Institutional Ownership Trends for Owens & Minor.

OMI stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Parametric Portfolio Associates LLC, SG Americas Securities LLC, LSV Asset Management, Wells Fargo & Company MN, GSA Capital Partners LLP, Cubist Systematic Strategies LLC and Aperio Group LLC. View Insider Buying and Selling for Owens & Minor.

OMI stock was bought by a variety of institutional investors in the last quarter, including Blackstone Group Inc, Invesco Ltd., Renaissance Technologies LLC, Morgan Stanley, BlackRock Inc., Marshall Wace North America L.P., Bank of New York Mellon Corp and Commonwealth Bank of Australia. View Insider Buying and Selling for Owens & Minor.

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OMI stock can currently be purchased for approximately $5.61.

Owens & Minor has a market capitalization of $353.21 million and generates $9.84 billion in revenue each year. The company earns $-437,010,000.00 in net income (profit) each year or $1.15 on an earnings per share basis. Owens & Minor employs 17,900 workers across the globe.View Additional Information About Owens & Minor.

The official website for Owens & Minor is http://www.owens-minor.com/.

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at 804-723-7000 or via email at [email protected]